Continuation of epidermal growth factor tyrokine kinase inhibitor with or without chemotherapy beyond gradual progression in non-small cell lung cancer patients.

Ling Peng,Qiong Zhao,Yina Wang,Haibo Mou,Yemin Tang,Danna Hu,Lei Zeng,Bo Zhao

Continuation of epidermal growth factor tyrokine kinase inhibitor with or without chemotherapy beyond gradual progression in non-small cell lung cancer patients.

2016

Ling Peng
Qiong Zhao
Yina Wang
Haibo Mou
Yemin Tang
Danna Hu
Lei Zeng
Bo Zhao

e20531Background: Several studies have demonstrated that continuous administration of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) could provide addtitional survival benefi...

Keywords:

Gradual progression
Epidermal growth factor
Cell
Cancer research
Pathology
Lung cancer
Medicine
Kinase
Chemotherapy
egfr tki
epidermal growth factor receptor tyrosine kinase
non small cell

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations